It’s well understood in nearly every corner of the healthcare space that continuous, real-time monitoring of an individual’s biomarkers offers nearly limitless potential to advance medicine. But no technology has made non-invasive, microneedle-free access to biomarker-rich interstitial fluid (ISF) possible—until now.
At Kiffik, we’ve developed novel technology that allows completely non-invasive access to interstitial fluid that fits in a wearable, connected device capable of transmitting health data from nearly anywhere in the world.
By partnering with medical researchers, biopharmaceuticals, or health tech, Kiffik technology can rapidly expand the understanding of diseases, unleash new possibilities in preventive medicine, accelerate the discovery and development of new therapeutics, and empower patients to proactively manage their health.
Kiffik technology offers the opportunity to drive nearly limitless advances across healthcare for humans and animals. Read the white paper the offers potential uses in diagnostics and drug development.
Kiffik Biomedical receives GHP Biotechnology award for its remarkable wearable device that offers continuous access to interstitial fluid in humans and animals.
Contact us regarding partnering
*Investigational Device. Limited by federal law to investigational use.
